Cargando…
Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies
Epilepsy is a multifactorial neurologic disease that often leads to many devastating disabilities and an enormous burden on the healthcare system. Until now, drug-resistant epilepsy has presented a major challenge for approximately 30% of the epileptic population. The present article summarizes the...
Autores principales: | Yang, Chih-Sheng, Wu, Man-Chun, Lai, Ming-Chi, Wu, Sheng-Nan, Huang, Chin-Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487685/ https://www.ncbi.nlm.nih.gov/pubmed/37685950 http://dx.doi.org/10.3390/ijms241713143 |
Ejemplares similares
-
Antiseizure Medications in Alzheimer’s Disease from Preclinical to Clinical Evidence
por: Bosco, Francesca, et al.
Publicado: (2023) -
Drug repositioning in epilepsy reveals novel antiseizure candidates
por: Brueggeman, Leo, et al.
Publicado: (2018) -
Teratogenicity and Antiseizure Medications
por: Meador, Kimford
Publicado: (2020) -
Antiseizure medications and pregnancy
por: Moores, Ginette, et al.
Publicado: (2021) -
Response to subsequent antiseizure medications after first antiseizure medication failure in newly diagnosed epilepsy
por: Hersi, Hire, et al.
Publicado: (2022)